PMC reviews insights from the 41st JP Morgan Healthcare conference, focusing on some of the new treatments and technologies to watch out for in the pharma industry this year – and highlighting challenges to progress.
Medical affairs is an increasingly complex discipline. It is vital that the team is highly trained and able to adapt to an evolving environment, liaising effectively with stakeholders to communicate value and bring new treatments to the market. Read on to discover some of the challenges and trends affecting the sector.
